136 related articles for article (PubMed ID: 26795298)
1. Flax lignan concentrate reverses alterations in blood pressure, left ventricular functions, lipid profile and antioxidant status in DOCA-salt induced renal hypertension in rats.
Sawant SH; Bodhankar SL
Ren Fail; 2016; 38(3):411-23. PubMed ID: 26795298
[TBL] [Abstract][Full Text] [Related]
2. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
Prahalathan P; Kumar S; Raja B
Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
[TBL] [Abstract][Full Text] [Related]
3. Omega-3-fatty acid adds to the protective effect of flax lignan concentrate in pressure overload-induced myocardial hypertrophy in rats via modulation of oxidative stress and apoptosis.
Ghule AE; Kandhare AD; Jadhav SS; Zanwar AA; Bodhankar SL
Int Immunopharmacol; 2015 Sep; 28(1):751-63. PubMed ID: 26277701
[TBL] [Abstract][Full Text] [Related]
4. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
Silambarasan T; Raja B
Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats.
Safaeian L; Emami R; Hajhashemi V; Haghighatian Z
Biomed Pharmacother; 2018 Apr; 100():147-155. PubMed ID: 29428662
[TBL] [Abstract][Full Text] [Related]
6. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.
Bhatia J; Tabassum F; Sharma AK; Bharti S; Golechha M; Joshi S; Sayeed Akhatar M; Srivastava AK; Arya DS
Cardiovasc Toxicol; 2011 Sep; 11(3):272-9. PubMed ID: 21748534
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
Jackson D; Connolly K; Batacan R; Ryan K; Vella R; Fenning A
Molecules; 2018 Jun; 23(7):. PubMed ID: 29932135
[TBL] [Abstract][Full Text] [Related]
8. Modulatory effect of sesamol on DOCA-salt-induced oxidative stress in uninephrectomized hypertensive rats.
Hemalatha G; Pugalendi KV; Saravanan R
Mol Cell Biochem; 2013 Jul; 379(1-2):255-65. PubMed ID: 23576423
[TBL] [Abstract][Full Text] [Related]
9. Effect of morin, a flavonoid against DOCA-salt hypertensive rats: a dose dependent study.
Prahalathan P; Kumar S; Raja B
Asian Pac J Trop Biomed; 2012 Jun; 2(6):443-8. PubMed ID: 23569947
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and Renoprotective Effects of Dietary Flaxseed and its Mechanism of Action in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
Watanabe Y; Ohata K; Fukanoki A; Fujimoto N; Matsumoto M; Nessa N; Toba H; Kobara M; Nakata T
Pharmacology; 2020; 105(1-2):54-62. PubMed ID: 31514180
[TBL] [Abstract][Full Text] [Related]
11. Preventive Beneficial Effect of an Aqueous Extract of Phyllanthus amarus Schum. and Thonn. (Euphorbiaceae) on DOCA-Salt-Induced Hypertension, Cardiac Hypertrophy and Dysfunction, and Endothelial Dysfunction in Rats.
Yao NA; Niazi ZR; Najmanová I; Kamagaté M; Said A; Chabert P; Auger C; Die-Kakou H; Schini-Kerth V
J Cardiovasc Pharmacol; 2020 Jun; 75(6):573-583. PubMed ID: 32187164
[TBL] [Abstract][Full Text] [Related]
12. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
[TBL] [Abstract][Full Text] [Related]
13. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
[TBL] [Abstract][Full Text] [Related]
14. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
Brown L; Duce B; Miric G; Sernia C
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
[TBL] [Abstract][Full Text] [Related]
15. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway.
Wenceslau CF; Rossoni LV
J Hypertens; 2014 Mar; 32(3):542-54. PubMed ID: 24309491
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats.
Galisteo M; García-Saura MF; Jiménez R; Villar IC; Zarzuelo A; Vargas F; Duarte J
Mol Cell Biochem; 2004 Apr; 259(1-2):91-9. PubMed ID: 15124912
[TBL] [Abstract][Full Text] [Related]
17. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
Ndisang JF; Jadhav A
J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817
[TBL] [Abstract][Full Text] [Related]
18. Isolation, characterization and antihyperlipidemic activity of secoisolariciresinol diglucoside in poloxamer-407-induced experimental hyperlipidemia.
Zanwar AA; Hegde MV; Rojatkar SR; Sonawane KB; Rajamohanan PR; Bodhankar SL
Pharm Biol; 2014 Sep; 52(9):1094-103. PubMed ID: 24649910
[TBL] [Abstract][Full Text] [Related]
19. Effects of omapatrilat on blood pressure and renal injury in L-NAME and L-NAME plus DOCA-treated rats.
Rodriguez-Gomez I; Wangensteen R; Atucha NM; O'Valle F; Del Moral RG; Garcia-Estañ J; Vargas F; Osuna A
Am J Hypertens; 2003 Jan; 16(1):33-8. PubMed ID: 12517680
[TBL] [Abstract][Full Text] [Related]
20. Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist.
Kubacka M; Zadrożna M; Nowak B; Kotańska M; Filipek B; Waszkielewicz AM; Marona H; Mogilski S
Hypertens Res; 2019 Aug; 42(8):1125-1141. PubMed ID: 30872813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
